← Back to headlines
Merck's Capvaxive Pneumococcal Shot Granted US Label Expansion
Merck has received a U.S. label expansion for its Capvaxive pneumococcal shot, broadening its approved uses.
18 Jun, 12:22 — 18 Jun, 12:22
Sources
Showing 1 of 1 sources
Related Stories
Meta Agrees to Up to $18 Billion Settlement Over Social Media Addiction Claims
11m ago
Apple Confirms September 9 Date for Next iPhone Launch Event
19m ago
IMF Chief Warns Global Economy Faces Energy Shocks and Fiscal Pressures
21m ago
Abercrombie & Fitch Shares Surge on Strong Second-Quarter Earnings and Raised Guidance
36m ago